60 DEGREES PHARMACEUTICALS, INC. Current Liabilities
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Current Liabilities of $1.61 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $1.61M.
- 2026-03-31: Liabilities, Current $1.88M.
- 2025-12-31: Liabilities, Current $1.84M.
- 2025-09-30: Liabilities, Current $2.20M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $1.61M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.88M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.84M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.20M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.69M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.80M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.66M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.22M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.84M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.48M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $28.86M 10-Q · filed 2023-08-25 |
| 2022-12-31 | $23.92M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |